Who to call at Lexeo Therapeutics, Inc., and when
Fundz watches for the moments Lexeo Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Lexeo Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lexeo Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lexeo Therapeutics, Inc.. With Fundz connected, it knows.
Lexeo Therapeutics, Inc.
The company completed buying or selling a business or major assets. An 8-K is the notice a US public company must file within four business days of a major event.
www.lexeotx.comAI Executive Summary
AI-powered analysis of 8-K filing content
Lexeo Therapeutics completed its acquisition of Mantle Therapeutics on September 29, 2026, with Mantle becoming a wholly owned subsidiary. This strategic transaction expands Lexeo's therapeutic portfolio and innovation capabilities.
Key Takeaways
Acquisition of Mantle Therapeutics was completed on September 29, 2026, following the Merger Agreement dated September 16, 2026
Mantle Therapeutics is now a wholly owned subsidiary of Lexeo following the merger of Lexeo's subsidiary Magma Merger Sub Inc. with Mantle
2 more takeaways
Related Filings (1)
1 more filing from Lexeo Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Lexeo Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.